Acinetobacter baumannii strains isolated from patients in intensive care units in Goiânia, Brazil: molecular and drug susceptibility profiles
Nenhuma Miniatura disponível
Data
2017
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Resistance to antimicrobial agents is increasing worldwide and imposes significant life threatening risks to several different populations, especially those in intensive care units
(ICUs). Bacteria can quickly develop or acquire resistance to antimicrobial drugs, and com bined with their intrinsic potential to cause disease in humans, these bacteria can become
deadly. Among Gram-negative bacteria, Acinetobacter baumannii is notorious as a frequent
opportunistic pathogen associated with critically ill patients, and understanding the genetic
basis of A. baumannii resistance to beta-lactams among patients in ICUs will result in better
protocols to prevent the development of resistance as well as improved treatment regimens.
In this study, we assessed 1333 patients in five ICUs, 56 of whom developed A. baumannii
infections. Most of the A. baumannii isolates were resistant to beta-lactam antimicrobial
drugs, specifically, 3rd- and 4th-generation cephalosporins and carbapenems, and 91.1% of
the isolates were multi-drug resistant (MDR). The most frequent OXA gene present was
OXA-23 (55.1%), which is significantly associated with MDR strains. Most of the A. bauman nii isolates (76.8%) were capable of forming a biofilm. The antimicrobial drug classes that
were effective against most of these isolates were polymyxins and tigecycline. The molecu lar profile of the isolates allowed detection of 12 different clusters comprising 2 to 8 isolates
each. In conclusion, our data indicate a high incidence of resistance to carbapenems as well
as MDR strains among the observed A. baumannii isolates, most of which exhibited a high
prevalence of OXA-23 gene expression. Only a few selective drugs were effective, reinforc ing the notion that bacterial resistance is an emerging problem that should be prioritized in
every healthcare facility.
Descrição
Palavras-chave
Citação
CASTILHO, Suellen Rocha Araújo et al. Acinetobacter baumannii strains isolated from patients in intensive care units in Goiânia, Brazil: molecular and drug susceptibility profiles. Plos One, San Francisco, v. 12, n. 5, e0176790, 2017. DOI: 10.1371/journal.pone.0176790. Disponível em: https://pubmed.ncbi.nlm.nih.gov/28475585/. Acesso em: 4 jul. 2025.